Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. Enforesys (Cytel)
BrandsEnforesys (Cytel)

How AI describes Enforesys (Cytel)

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Enforesys (Cytel) logoEnforesys (Cytel)cytel.com

Cytel's Enforesys is a Monte Carlo simulation software that forecasts clinical trial enrollment by incorporating site-level data and real-world variables. It helps pharmaceutical teams anticipate recruitment challenges, assess feasibility, and optimize trial operations through probabilistic modeling.

Ownership
Part ofCytel logoCytel
Enforesys (Cytel) logoEnforesys (Cytel)

Parse Score

43.8

#90 of 193 in Clinical Trial Management Software

Strength17
Reach36
Authority0

Work at Enforesys (Cytel)?

Claim this profile for the full report: every prompt where Enforesys (Cytel) appears, who is gaining, and what AI says about you. Claiming is free and unlocks your brand’s ambient view. Monitoring a market is the paid layer on top.

Verified with a work email.

Track this weekly.

Monitor Enforesys (Cytel)

Sources

cytel.com shapes more of what AI says about Enforesys (Cytel) than any other source, at 100% of its citations.

AI questions where Enforesys (Cytel) appears

Always know where you stand in AI

Start monitoring Enforesys (Cytel)

The market map

Clinical Trial Management Software →
10%20%50%Category leadersSpecialistsIn the mixLong tailNamed in more AI answers →Appears earlier in the answer →MedidataVeevaIQVIAOracleRealTime eClinic…AdvarraCastor EDCSASOCT Clinical Tri…MedableHungaroTrialCrucial Data Sol…Trial InteractiveCloudbyz

Where AI ranks Enforesys (Cytel)

Clinical Trial Management Software#90
Prompt
Prompt visibility
What’s the best option for trial criteria variations and enrollment simulations?5.2